Capital International Inc. CA Raises Stock Holdings in HUTCHISON CHINA/S (NASDAQ:HCM)

Capital International Inc. CA boosted its holdings in HUTCHISON CHINA/S (NASDAQ:HCM) by 8.6% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 4,597,386 shares of the company’s stock after acquiring an additional 365,374 shares during the period. HUTCHISON CHINA/S makes up 1.6% of Capital International Inc. CA’s portfolio, making the stock its 12th largest holding. Capital International Inc. CA’s holdings in HUTCHISON CHINA/S were worth $115,256,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. PNC Financial Services Group Inc. raised its position in HUTCHISON CHINA/S by 109.1% in the 4th quarter. PNC Financial Services Group Inc. now owns 1,677 shares of the company’s stock worth $43,000 after buying an additional 875 shares during the last quarter. Parallel Advisors LLC increased its position in shares of HUTCHISON CHINA/S by 153.3% during the 4th quarter. Parallel Advisors LLC now owns 1,743 shares of the company’s stock valued at $44,000 after purchasing an additional 1,055 shares during the last quarter. DekaBank Deutsche Girozentrale purchased a new stake in shares of HUTCHISON CHINA/S during the 4th quarter valued at about $64,000. Quadrant Capital Group LLC purchased a new stake in shares of HUTCHISON CHINA/S during the 4th quarter valued at about $68,000. Finally, Tower Research Capital LLC TRC increased its position in shares of HUTCHISON CHINA/S by 19.5% during the 4th quarter. Tower Research Capital LLC TRC now owns 3,783 shares of the company’s stock valued at $95,000 after purchasing an additional 617 shares during the last quarter. 28.07% of the stock is owned by institutional investors and hedge funds.

HCM has been the subject of several research reports. Zacks Investment Research lowered shares of HUTCHISON CHINA/S from a “buy” rating to a “hold” rating in a research report on Tuesday, March 17th. Goldman Sachs Group initiated coverage on shares of HUTCHISON CHINA/S in a research report on Thursday, February 20th. They set a “buy” rating for the company. BidaskClub lowered shares of HUTCHISON CHINA/S from a “strong-buy” rating to a “buy” rating in a research report on Friday, March 13th. Cantor Fitzgerald initiated coverage on shares of HUTCHISON CHINA/S in a research report on Thursday, March 12th. They set an “overweight” rating for the company. Finally, ValuEngine raised shares of HUTCHISON CHINA/S from a “hold” rating to a “buy” rating in a research report on Tuesday, February 25th. One investment analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. HUTCHISON CHINA/S currently has a consensus rating of “Buy” and a consensus price target of $29.00.

Shares of NASDAQ HCM traded up $0.28 during midday trading on Thursday, hitting $19.04. 44,531 shares of the company’s stock traded hands, compared to its average volume of 234,797. The firm has a fifty day moving average of $23.67 and a 200 day moving average of $22.93. The stock has a market capitalization of $2.43 billion, a price-to-earnings ratio of -23.80 and a beta of 0.78. The company has a debt-to-equity ratio of 0.10, a quick ratio of 2.66 and a current ratio of 2.80. HUTCHISON CHINA/S has a 1 year low of $14.74 and a 1 year high of $32.55.

HUTCHISON CHINA/S Company Profile

Hutchison China MediTech Limited, a commercial-stage biopharmaceutical company, engages in discovery, development, and commercialization of targeted therapeutics and immunotherapies for oncology and immunological diseases in the People's Republic of China and Hong Kong. The company operates through Innovation Platform and Commercial Platform segments.

Further Reading: What is a Futures Contract?

Want to see what other hedge funds are holding HCM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HUTCHISON CHINA/S (NASDAQ:HCM).

Institutional Ownership by Quarter for HUTCHISON CHINA/S (NASDAQ:HCM)

Receive News & Ratings for HUTCHISON CHINA/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HUTCHISON CHINA/S and related companies with MarketBeat.com's FREE daily email newsletter.